Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

Abramson Cancer Center at Penn Medicine1 site in 1 country150 target enrollmentFebruary 1, 2010

ConditionsNo Restrictions on Diagnosis

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: No Restrictions on Diagnosis
Sponsor: Abramson Cancer Center at Penn Medicine
Enrollment: 150
Locations: 1
Primary Endpoint: Number of Adverse Events
Status: Recruiting
Last Updated: 9 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This clinical research protocol is intended to allow for bone marrow aspirate/biopsy and blood specimens to be collected for research purposes, specifically allowing subjects the option of sedation during the bone marrow procedure. Samples will be banked for future research related to cancer and other diseases. Researchers hope this protocol will improve the collection of research correlative and translational biopsy specimens for clinical research.

Registry

clinicaltrials.gov

Start Date

February 1, 2010

End Date

May 7, 2026

Last Updated

9 months ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Abramson Cancer Center at Penn Medicine

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Planned procedure including a bone marrow aspirate and/or bone marrow biopsy
•The procedure is planned for the purpose of obtaining a research specimen (as part of another research study or as part of this stand-alone sample collection protocol.). Procedures with a dual purpose (i.e. to obtain both clinically-indicated specimens and research specimens) are permitted, but procedures to obtain clinical specimens only are not permitted.
•All subjects must provide written informed consent for the biopsy procedure, the collection of bone marrow and blood specimens for research purposes and (if planned) the administration of sedation.

Exclusion Criteria

•Moderate sedation may not be administrated to subjects with a clinical contraindication to its provision, or if the investigator believes that administration of moderate sedation would constitute under risk to the subject.